Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Filings indexed 835 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 82% confidence The document is a compliance statement filed under SEBI (Listing Obligations and Disclosure Requirements) Regulation 33, confirming no deviation in the utilisation of funds raised through a Rights Issue. It does not contain financial statements or constitute an annual or interim report, nor is it announcing the initial fundraising itself. It is a regulatory disclosure required by the stock exchanges, fitting the general “Regulatory Filings” category.
2025-11-13 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 90% confidence The document is an official board meeting outcome notification filed under Regulation 30 of SEBI LODR. It contains the full Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2025, including actual financial statements and the auditor’s limited review report. This represents a comprehensive interim/quarterly financial report rather than a brief earnings summary or mere publication notice, so it falls under Interim / Quarterly Report (IR). H1 2025
2025-11-13 English
No Deviation Or Variation in the use of Proceeds raised through Right Issue
Regulatory Filings
2025-11-13 English
Unaudited Financial results for the Quarter and half year ended September 30, 2025
Regulatory Filings
2025-11-13 English
Sadhana Nitro Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve SADHANA NITROCHEM LTD. has ....
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board Meeting scheduled for November 13, 2025. The purpose of the meeting includes considering and approving unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The document references regulatory compliance under SEBI (LODR) Regulations and insider trading regulations. The document is short (2225 characters) and serves as an intimation or announcement of a board meeting rather than containing the actual financial results or detailed report. Therefore, it is not an Interim/Quarterly Report (IR) or Annual Report (10-K), but rather a Regulatory Filing (RNS) notifying the market of the upcoming board meeting and expected financial results approval.
2025-11-07 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-11-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.